50850-19-6

Basic information

• Product Name: Carbamicacid,(2-amino-2-iminoethyl)-,phenylmethylester,monohydrochloride
• Synonyms: Carbamicacid,(2-amino-2-iminoethyl)-,phenylmethylester,monohydrochloride;(2-Amino-2-iminoethyl)carbamic acid phenylmethyl ester monohydrochloride;(2-Amino-2-iminoethyl)carbamic acid benzyl ester hydrochloride;(2-amino-2-iminoethyl)phenylmethyl Carbamic acidester, monohydrochloride;Benzyl [amidinomethyl]carbamate hydrochloride;(2-aMino-2-iMinoethyl)phenylMethyl CarbaMic acidester, Monohydro;N-(2-AMino-2-iMinoethyl)carbaMic Acid PhenylMethyl Ester Hydrochloride
• CAS NO: 50850-19-6
• Molecular Formula: C₁₀H₁₃N₃O₂*ClH
• Molecular Weight: 243.69006
• Product Categories: Aromatics;Intermediates & Fine Chemicals;Miscellaneous Reagents;Pharmaceuticals
• Mol File: 50850-19-6.mol

Chemical Properties

• Melting Point: 75-77°C
• Boiling Point: 409.6°C at 760 mmHg
• Flash Point: 201.5°C
• Appearance: /
• Vapor Pressure: 4.16E-07mmHg at 25°C
• Storage Temp.: Hygroscopic, -20?C Freezer, Under Inert Atmosphere
• CAS DataBase Reference: Carbamicacid,(2-amino-2-iminoethyl)-,phenylmethylester,monohydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamicacid,(2-amino-2-iminoethyl)-,phenylmethylester,monohydrochloride(50850-19-6)
• EPA Substance Registry System: Carbamicacid,(2-amino-2-iminoethyl)-,phenylmethylester,monohydrochloride(50850-19-6)

Safety Data

• Hazardous Substances Data: 50850-19-6(Hazardous Substances Data)

Usage

Chemical Properties

Pale Yellow Solid

InChI:InChI=1/C10H13N3O2.ClH/c11-9(12)6-13-10(14)15-7-8-4-2-1-3-5-8;/h1-5H,6-7H2,(H3,11,12)(H,13,14);1H

Upstream product

• 3589-41-1 phenylmethyl cyanomethylcarbamate 
• 142065-78-9 methyl 2-(((benzyloxy)carbonyl)amino)acetimidate 

Downstream Products

• 76196-76-4 Ethyl 2-benzyloxycarbonylaminomethylpyrimidine-5-carboxylate 
• 865365-67-9 [5-(dimethylamino-methyleneamino)-pyrimidin-2-ylmethyl]-carbamic acid benzyl ester 
• 76196-77-5 2-Benzyloxycarbonylaminomethylpyrimidine-5-carboxylic acid 
• 1418131-84-6 benzyl [(4-oxo-4,5,7,8-tetrahydro-3H-pyrano[4,3-d]pyrimidin-2-yl)methyl]carbamate 

Relevant articles and documents

Small-Molecule Inhibition of the C. difficile FAS-II Enzyme, FabK, Results in Selective Activity

Clostridioides difficile infection (CDI) is a leading cause of significant morbidity, mortality, and healthcare-related costs in the United States. After standard therapy, recurrence rates remain high, and multiple recurrences are not uncommon. Causes inc

4-OXO-3,5,7,8-TETRAHYDRO-4H-PYRANO {4,3-D} PYRMINIDINYL COMPOUNDS FOR USE AS TANKYRASE INHIBITORS

The present invention provides for compounds of formula (I) wherein R1 and R2 are defined herein. The present invention also provides for pharmaceutical compositions and combinations comprising a compound of formula (I) as well as fo

Phenylimidazole derivatives as new inhibitors of bacterial enoyl-ACP reductase FabK

Novel FabK inhibitors with antibacterial activity against Streptococcus pneumoniae were synthesized and evaluated. Through SAR studies of our initial hit compound 2-(1H-benz[d]imidazol-2-ylthio)-N-(6-methoxycarbonylbenzo[d]thiazol-2-yl)acetamide, a series of novel phenylimidazole derivatives were discovered as potent FabK inhibitors.

Phenylimidazole derivatives as specific inhibitors of bacterial enoyl-acyl carrier protein reductase FabK

Bacterial enoyl-acyl carrier protein (ACP) reductases (FabI and FabK) catalyze the final step in each cycle of bacterial fatty acid biosynthesis and are attractive targets for the development of new antibacterial agents. Here, we report the development of novel FabK inhibitors with antibacterial activity against Streptococcus pneumoniae. Based on structure-activity relationship (SAR) studies of our screening hits, we have developed novel phenylimidazole derivatives as potent FabK inhibitors.